According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), a lawsuit accuses biotechnology company Ocular Therapeutix of spreading false information about EyePoint and its product Duravyu.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The legal document states that Ocular Therapeutix disseminated false information about EyePoint's business and the Duravyu product through public statements. Details of the case are still being further disclosed, and this matter may have a significant impact on the market reputation and investor relations of both companies.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
The Smarter Web Company CEO: Q2 marks the company's shift from a Bitcoin treasury to an enhanced Bitcoin company
ForesightNews•2026/06/27 10:04
JPMorgan Chase: SpaceX Inclusion in Nasdaq 100 Index Could Trigger $4.3 Billion Passive Fund Inflows
BlockBeats•2026/06/27 09:54
Exchange leads you to trending coins: AAVE's popularity rises, up 11.53% in 24H
AiCoin•2026/06/27 09:33
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$60,307.76
+1.02%
Ethereum
ETH
$1,579.4
+1.69%
Tether USDt
USDT
$0.9985
-0.01%
USDC
USDC
$0.9997
+0.01%
XRP
XRP
$1.06
+2.51%
Solana
SOL
$71.67
+3.93%
TRON
TRX
$0.3205
-0.47%
Hyperliquid
HYPE
$62.76
-0.01%
Dogecoin
DOGE
$0.07522
+1.74%
Zcash
ZEC
$407.23
+1.61%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now